170 related articles for article (PubMed ID: 38682294)
1. Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders.
Chu R; Wang Y; Kong J; Pan T; Yang Y; He J
J Mater Chem B; 2024 May; 12(20):4759-4784. PubMed ID: 38682294
[TBL] [Abstract][Full Text] [Related]
2. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Qiu M; Li Y; Bloomer H; Xu Q
Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
[TBL] [Abstract][Full Text] [Related]
4. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid.
Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ
Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955
[TBL] [Abstract][Full Text] [Related]
5. Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
Duan W; Liu Y
Drug Des Devel Ther; 2018; 12():2149-2161. PubMed ID: 30034219
[TBL] [Abstract][Full Text] [Related]
6. Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery
Zhang T; Yin H; Li Y; Yang H; Ge K; Zhang J; Yuan Q; Dai X; Naeem A; Weng Y; Huang Y; Liang XJ
iScience; 2024 Jun; 27(6):109804. PubMed ID: 38770138
[TBL] [Abstract][Full Text] [Related]
7. A tale of nucleic acid-ionizable lipid nanoparticles: Design and manufacturing technology and advancement.
De A; Ko YT
Expert Opin Drug Deliv; 2023 Jan; 20(1):75-91. PubMed ID: 36445261
[TBL] [Abstract][Full Text] [Related]
8. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
Tenchov R; Bird R; Curtze AE; Zhou Q
ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
[TBL] [Abstract][Full Text] [Related]
9. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
Zhang J; Haas RM; Leone AM
Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
[TBL] [Abstract][Full Text] [Related]
10. Delivery of oligonucleotides with lipid nanoparticles.
Wang Y; Miao L; Satterlee A; Huang L
Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
[TBL] [Abstract][Full Text] [Related]
11. A review of DNA nanoparticles-encapsulated drug/gene/protein for advanced controlled drug release: Current status and future perspective over emerging therapy approaches.
Kashani GK; Naghib SM; Soleymani S; Mozafari MR
Int J Biol Macromol; 2024 May; 268(Pt 1):131694. PubMed ID: 38642693
[TBL] [Abstract][Full Text] [Related]
12. Lipid-based nanoparticle technologies for liver targeting.
Böttger R; Pauli G; Chao PH; Al Fayez N; Hohenwarter L; Li SD
Adv Drug Deliv Rev; 2020; 154-155():79-101. PubMed ID: 32574575
[TBL] [Abstract][Full Text] [Related]
13. Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids.
Sato Y
Chem Pharm Bull (Tokyo); 2021; 69(12):1141-1159. PubMed ID: 34853281
[TBL] [Abstract][Full Text] [Related]
14. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
15. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
16. Increase Nebulization Stability of Lipid Nanoparticles by Integrating a DNA Supramolecular Hydrogel.
Wei X; Li Y; Cheng X; Wen Y; Yuan W; Chen R; Meng S; Lu X; Yu Z; Xu L; Liu D; Dong Y
ACS Macro Lett; 2023 Jun; 12(6):745-750. PubMed ID: 37207332
[TBL] [Abstract][Full Text] [Related]
17. A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation.
Paunovska K; Sago CD; Monaco CM; Hudson WH; Castro MG; Rudoltz TG; Kalathoor S; Vanover DA; Santangelo PJ; Ahmed R; Bryksin AV; Dahlman JE
Nano Lett; 2018 Mar; 18(3):2148-2157. PubMed ID: 29489381
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.
Battaglia L; Gallarate M
Expert Opin Drug Deliv; 2012 May; 9(5):497-508. PubMed ID: 22439808
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials.
Kabil MF; Badary OA; Bier F; Mousa SA; El-Sherbiny IM
J Liposome Res; 2024 Mar; 34(1):135-177. PubMed ID: 37144339
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
Sato Y; Matsui H; Sato R; Harashima H
J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
